Table 4

Logistic regression model for factors related with poor clinical outcome at 3 months

OR95% CIP valueOR95% CIP value
sTWEAK ≥5600 pg/mL3.122.13 to 4.55<0.00011.570.87 to 2.830.129
ICH basal volume1.031.03 to 1.04<0.00011.041.03 to 1.05<0.0001
Leukoaraiosis4.162.92 to 5.86<0.00014.312.89 to 6.42<0.0001
ICH growth1.871.29 to 2.710.0011.610.88 to 2.940.123
sTWEAK×ICH growth2.231.40 to 3.550.001
OR95% CIP valueOR95% CIP value
sTWEAK ≥5600 pg/mL3.122.13 to 4.55<0.00011.670.93 to 2.990.086
ICH basal volume1.031.03 to 1.04<0.00011.031.03 to 1.04<0.0001
No LARef.Ref
Grade I1.431.06 to 1.920.0192.631.66 to 4.14<0.0001
Grade II2.471.79 to 3.39<0.00016.053.67 to 9.98<0.0001
Grade III3.071.89 to 4.97<0.000117.035.72 to 50.68<0.0001
ICH growth1.871.29 to 2.710.0011.490.82 to 2.730.193
sTWEAK×ICH growth2.011.27 to 3.230.003
  • *Adjusted by age, previous mRS, atrial fibrillation, previous anticoagulants, temperature at admission, glucose, leucocytes, C reactive protein, LDL cholesterol, sedimentation rate, basal ICH volume, presence of LA, ICH growth and sTWEAK ≥5600 pg/mL.

  • †Adjusted by the same variables; the presence of LA was replaced by the three grades of LA.

  • HDL, High Density Lipoprotein; ICH, intracerebral haemorrhage; LA, leukoaraiosis; LDL, Low Density Lipoprotein; mRS, modified Rankin Scale; sTWEAK, soluble tumour necrosis factor-like weak inducer of apoptosis.